Methoxyphenamine Hydrochloride/Narcosine/Aminophylline/Chlorphenamine Maleate

盐酸甲氧那明/那可丁/氨茶碱/马来酸氯苯那敏

Report date: 2023/08/09 18:30:32
NME

Base Information

Drug NameMethoxyphenamine Hydrochloride/Narcosine/Aminophylline/Chlorphenamine Maleate
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionBeta-2 adrenergic receptor agonists3',5'-cyclic phosphodiesterase inhibitorsHistamine H1 receptor antagonists
TargetsBeta-2 adrenergic receptor3',5'-cyclic phosphodiesteraseHistamine H1 receptor
Therapy Area/IndicationsAsthmaBronchitis
Global Approved IndicationsAsthmaBronchitis
Approved Indications in ChinaAsthmaBronchitis
Original Approved Country/TerritoryMainland China
Original Approved Date1998/01/01
Country/TerritoryMainland China
CombinationsYes Methoxyphenamine HydrochlorideNarcosineAminophylline
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesDaiichi Sankyo Pharmaceutical(Shanghai) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Sine Pharmaceutical Laboratories Co Ltd
Inactive CompaniesN/A
Active IndicationsAsthmaBronchitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A